title: Guidelines for the management of diffuse large B-cell lymphoma.
authors.affiliation: Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK.
authors.forename: Sridhar
authors.initials: S
authors.lastname: Chaganti
authors.affiliation: Department of Clinical Oncology, Christie Hospital, Manchester, UK.
authors.forename: Tim
authors.initials: T
authors.lastname: Illidge
authors.affiliation: PET Imaging Centre, King's College London, King's Health Partners, St. Thomas' Hospital, London, UK.
authors.forename: Sally
authors.initials: S
authors.lastname: Barrington
authors.affiliation: Department of Haematology, West of Scotland Cancer Centre, Glasgow, UK.
authors.forename: Pam
authors.initials: P
authors.lastname: Mckay
authors.affiliation: Department of Medical Oncology, Christie Hospital, Manchester, UK.
authors.forename: Kim
authors.initials: K
authors.lastname: Linton
authors.affiliation: Department of Haematology, Royal Free Hospital, London, UK.
authors.forename: Kate
authors.initials: K
authors.lastname: Cwynarski
authors.affiliation: Department of Haematology, City Hospital, Nottingham, UK.
authors.forename: Andrew
authors.initials: A
authors.lastname: McMillan
authors.affiliation: Department of Medical Oncology, Southampton General Hospital, Southampton, UK.
authors.forename: Andy
authors.initials: A
authors.lastname: Davies
authors.affiliation: Department of Haematology, St Helier Hospital, Carshalton, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Stern
authors.affiliation: Department of Haematology, University College Hospital, London, UK.
authors.forename: Karl
authors.initials: K
authors.lastname: Peggs
mesh_terms: D006801:Humans; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D019468:Disease Management; D004317:Doxorubicin / Q000627:therapeutic use; D000073496:Frailty / Q000628:therapy; D015658:HIV Infections / Q000150:complications / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D016879:Salvage Therapy / Q000379:methods; D006113:United Kingdom; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D003520:Cyclophosphamide; D004317:Doxorubicin; D011241:Prednisone; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine
keywords: aggressive NHL; diffuse large B-cell lymphoma; non-Hodgkin lymphoma